Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Astrocytoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07544992
What this trial is testing

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype
City of Hope Medical Center 24
Testing effectiveness (Phase 2)Study completedNCT00921167
What this trial is testing

Evaluate the Efficacy of Bevacizumab Plus Irinotecan in Recurrent Gliomas

Who this might be right for
GlioblastomaAstrocytoma
Clinical Research Center for Solid Tumor, Korea 32
Early research (Phase 1)Ended earlyNCT01103375
What this trial is testing

Erlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more
Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Study completedNCT01498328
What this trial is testing

Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma

Who this might be right for
GlioblastomaSmall Cell GlioblastomaGiant Cell Glioblastoma+4 more
Celldex Therapeutics 127
Testing effectiveness (Phase 2)UnknownNCT04671459
What this trial is testing

TTFields and Radiosurgery of Recurrent Glioblastoma +/- 18F-Fluoro-Ethyl-Thyrosine

Who this might be right for
Glioblastoma MultiformeRecurrent Glioblastoma
Prof. Franciszek Lukaszczyk Memorial Oncology Center 40
Early research (Phase 1)Looking for participantsNCT04991870
What this trial is testing

Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM

Who this might be right for
Recurrent GliosarcomaRecurrent Supratentorial GlioblastomaSupratentorial Gliosarcoma
M.D. Anderson Cancer Center 25
Early research (Phase 1)Looking for participantsNCT05789394
What this trial is testing

Allogenic Adipose-Derived Mesenchymal Stem Cells for the Treatment of Recurrent Glioblastoma or Recurrent Astrocytoma in Patients Undergoing Craniotomy

Who this might be right for
Recurrent Glioblastoma, IDH-WildtypeRecurrent Astrocytoma, IDH-Mutant, Grade 4Astrocytoma, Grade IV
Mayo Clinic 20
Very early researchEnded earlyNCT04424966
What this trial is testing

Infigratinib in Recurrent High-Grade Glioma Patients

Who this might be right for
GliomaGlioblastomaGBM
Nader Sanai 7
Early research (Phase 1)Study completedNCT00087451
What this trial is testing

Safety Study of AP23573 in Patients With Progressive or Recurrent Glioma (8669-023)(COMPLETED)

Who this might be right for
Malignant GliomaGlioblastomaGliosarcoma
Merck Sharp & Dohme LLC 11
Early research (Phase 1)Looking for participantsNCT06097975
What this trial is testing

A Clinical Trial on Combined (Neo-)Adjuvant Intravenous Plus Intracranial Administration of Ipilimumab and Nivolumab in Recurrent Glioblastoma

Who this might be right for
Recurrent Glioblastoma
Universitair Ziekenhuis Brussel 18
Testing effectiveness (Phase 2)Study completedNCT01975701
What this trial is testing

BGJ398 in Patients With Recurrent GBM

Who this might be right for
Recurrent Glioblastoma or Other Glioma Subtypes
Novartis Pharmaceuticals 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07831187
What this trial is testing

Entacapone Plus Bevacizumab for Glioblastoma at First Recurrence

Who this might be right for
Glioblastoma
First Affiliated Hospital of Wenzhou Medical University 96
Not applicableNo Longer AvailableNCT02755987
What this trial is testing

Expanded Access to ANG1005 for Individual Patients

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaBreast Cancer With Recurrent Brain Metastases+1 more
Angiochem Inc
Testing effectiveness (Phase 2)Ended earlyNCT04421378
What this trial is testing

Selinexor in Combination With Standard of Care Therapy for Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
Glioblastoma Multiforme
Karyopharm Therapeutics Inc 74
Testing effectiveness (Phase 2)UnknownNCT04547855
What this trial is testing

Anlotinib Combined With Dose-dense Temozolomide for the First Recurrent or Progressive Glioblastoma After STUPP Regimen

Who this might be right for
Glioblastoma
Yonggao Mou 54
Testing effectiveness (Phase 2)Study completedNCT00002814
What this trial is testing

Combination Chemotherapy for Patients With Brain Cancer

Who this might be right for
Brain and Central Nervous System Tumors
Dartmouth-Hitchcock Medical Center 20
Testing effectiveness (Phase 2)Study completedNCT01756352
What this trial is testing

FET-PET for Evaluation of Response of Recurrent GBM to Avastin

Who this might be right for
Glioblastoma MultiformeGBM
Marcelo F. Di Carli, MD, FACC 13
Early research (Phase 1)Study completedNCT00107458
What this trial is testing

Valproic Acid in Treating Young Patients With Recurrent or Refractory Solid Tumors or CNS Tumors

Who this might be right for
Brain and Central Nervous System TumorsUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 26
Testing effectiveness (Phase 2)Study completedNCT01648348
What this trial is testing

Bevacizumab With or Without Anti-Endoglin Monoclonal Antibody TRC105 in Treating Patients With Recurrent Glioblastoma Multiforme

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 116
Early research (Phase 1)Ended earlyNCT02722512
What this trial is testing

Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine

Who this might be right for
Glioblastoma MultiformeAstrocytoma, Grade IIIAnaplastic Ependymoma+2 more
Ann & Robert H Lurie Children's Hospital of Chicago 10
Next Page